Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Operating Activities [Abstract]
Net Loss	$ (4,239,000)	$ (2,624,000)
Adjustments to reconcile net loss to cash used in operating activities:
Liability forgiveness	(776,000)	(551,000)
Liability forgiveness related party	0	(1,745,000)
Depreciation and Amortization	742,000	773,000
Revaluation of subscription agreements	(79,000)	0
Amortization of Debt Issuance Costs and Discounts	392,000	0
Share-based Payment Arrangement, Noncash Expense	5,000	478,000
Preferred shares interest expense, related party	0	291,000
Changes in operating assets and liabilities:
Accounts Receivable	110,000	365,000
Inventories	94,000	405,000
Accounts Payable and Accrued Liabilities	3,380,000	454,000
Accrued Payroll and Employee Compensation	66,000	84,000
Deferred Revenue	(553,000)	70,000
Other Assets and Liabilities, Net	(1,138,000)	564,000
Net Cash Used in Operating Activities	(1,996,000)	(1,436,000)
Financing activities:
Proceeds from Issuance of Preferred Stock and Preference Stock	2,735,000	0
Proceeds from Issuance of Unsecured Debt	667,000	0
Proceeds from Convertible Debt	375,000	0
Proceeds from Related Party Convertible Debt	200,000	0
Proceeds from Warrant Exercises	120,000	0
Proceeds from Issuance of Common Stock	115,000	480,000
Proceeds from Stock Options Exercised	76,000	0
Proceeds from debt-related party	500,000	523,000
Increase (Decrease) in Notes Payable, Related Parties, Current	(42,000)	0
Proceeds from (Repayments of) Lines of Credit	(2,000)	221,000
Net Cash Provided by Financing Activities	4,744,000	1,224,000
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(1,000)	0
Net Increase (Decrease) in cash and cash equivalents	2,747,000	(212,000)
Cash, Cash Equivalents, Beginning	149,000	341,000
Cash, Cash Equivalents, Ending	$ 2,896,000	$ 129,000